Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Talaris Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/06/2023 4 Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Paid exercise price by delivering 12,946 shares @ $3.08, valued at $39.9k
07/06/2023 4 Requadt Scott (Former Chief Executive Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Paid exercise price by delivering 11,786 shares @ $3.08, valued at $36.3k
06/09/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 75,001 shares @ $2.3879, valued at $179.1k
Sold 40,642 shares @ $2.4795, valued at $100.8k
Sold 25,419 shares @ $2.4642, valued at $62.6k
06/07/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 7,841 shares @ $2.5194, valued at $19.8k
Sold 25,549 shares @ $2.5283, valued at $64.6k
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 29 shares @ $2.05, valued at $59.5
02/23/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 3,500 shares @ $2.0529, valued at $7.2k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2022 4 Zdanowski Michael (Chief Technology Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 120,000 shares @ $0
09/13/2022 4 Krieger Nancy (Chief Medical Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 80,000 shares @ $0
09/13/2022 4 Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 80,000 shares @ $0
09/13/2022 4 Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 80,000 shares @ $0
08/23/2022 4 Ildstad Suzanne (Chief Scientific Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 525,000 shares @ $2.8, valued at $1.5M
08/02/2022 4 Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Bought 39,382 shares @ $4.25, valued at $167.4k
07/28/2022 4 Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Bought 5,528 shares @ $4.24, valued at $23.4k
Bought 3,090 shares @ $4.25, valued at $13.1k
07/26/2022 4 Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Bought 9,444 shares @ $3.7497, valued at $35.4k
07/25/2022 4 Nader Francois (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Bought 50,000 shares @ $3.52, valued at $176k
Bought 52,000 shares @ $3.62, valued at $188.2k
Disposed of 248,432 shares @ $0
Acquired 248,432 shares @ $0
Bought 36,500 shares @ $3.72, valued at $135.8k
Disposed of 138,500 shares @ $0
Acquired 138,500 shares @ $0
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Agarwala Sandip (10% Owner) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 14,501 options to buy @ $8.45, valued at $122.5k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Ildstad Suzanne (Chief Scientific Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Gifted 1,200,000 shares @ $0
Gifted 1,200,000 shares @ $0
Granted 150,000 options to buy @ $9.1, valued at $1.4M
02/02/2022 4 Krieger Nancy (Chief Medical Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 190,000 options to buy @ $9.1, valued at $1.7M
02/02/2022 4 Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Granted 1,470 shares @ $13, valued at $19.1k
Granted 500,000 options to buy @ $9.1, valued at $4.6M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy